Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (se deschide o fereastră nouă)

Ball AM, Winstead PS.

Sursă‎: Pharmacotherapy 2008;28(11):1383-90.

Index‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (se deschide o fereastră nouă)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (se deschide o fereastră nouă)

Charles A, Purtill M, Napolitano LM.

Sursă‎: Anaesth Intensive Care 2006;34(6):793-6.

Index‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (se deschide o fereastră nouă)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (se deschide o fereastră nouă)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Sursă‎: N Engl J Med. 2023 2;389(18):1649-59.

Index‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (se deschide o fereastră nouă)

Bloodless management of the anemic patient in the emergency department. (se deschide o fereastră nouă)

Johnson-Arbor K, Verstraete R

Sursă‎: Ann Emerg Med 2022;79(1):48-57.

Index‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (se deschide o fereastră nouă)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (se deschide o fereastră nouă)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Sursă‎: J Trauma 2008;65(2):285-97.

Index‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (se deschide o fereastră nouă)

Erythropoiesis in multiply injured patients. (se deschide o fereastră nouă)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Sursă‎: J Trauma 2006;61(5):1285-91.

Index‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (se deschide o fereastră nouă)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (se deschide o fereastră nouă)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Sursă‎: Arch Surg 2012;147(3):251-5.

Index‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (se deschide o fereastră nouă)

Zeugen Jehovas und Schwerverletzung mit drohender Hämorrhagie. Wie komplex ist die Behandlung? [Jehovah's Witnesses and severe injury with impending hemorrhaging: how complex is the treatment?] [German, English abstract] (se deschide o fereastră nouă)

Zeckey C, Vanin N, Neitzke G, Mommsen P, Bachmann S, Frink M, Wilhelmi M, Krettek C, Hildebrand F.

Sursă‎: Chirurg 2011;82(6):531-5.

Index‎: PubMed 21088815

DOI‎: 10.1007/s00104-010-1999-y

https://www.ncbi.nlm.nih.gov/pubmed/21088815 (se deschide o fereastră nouă)